| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |